ClinicalTrials.gg
RecruitingNCT06622525Updated Oct 2, 2024

Use of Sodium Bicarbonate As Prophylaxis for Kidney Damage in Patients with Heatstroke

An interventional study of Sodium bicarbonate and No intervention in Heat Stroke, Acute Kidney Injury and Acute Kidney Injury Due to Hypovolaemia, sponsored by Hospital General de Mexicali. Recruiting at 1 site in Mexico. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-02.

Sponsored by Hospital General de Mexicali · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
1
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study protocol aims to prevent the need for renal replacement therapy in patients with rhabdomyolysis secondary to heatstroke. It is based on previous studies showing that bicarbonate infusion reduces renal failure in similar contexts. The intervention will be conducted at the General Hospital of Mexicali during the summer, targeting the prevention of renal failure and reducing the necessity for renal replacement therapy.

Read the detailed description

The present study protocol explores the possibility of preventing the need for renal replacement therapy in patients who develop rhabdomyolysis secondary to heatstroke. This is based on previous studies that have used bicarbonate infusion in the context of rhabdomyolysis secondary to compartment syndrome, finding a lower incidence of renal failure. Due to the aforementioned, we propose to carry out a similar intervention at the General Hospital of Mexicali, where there is a significant incidence of heatstroke during the summer months. The aim is to determine whether this intervention is useful in preventing the development of renal failure and the requirement for renal replacement therapy.

02

Conditions studied

  • Heat Stroke
  • Acute Kidney Injury
  • Acute Kidney Injury Due to Hypovolaemia
03

In context

Heat Stroke

21 studies on the registry are indexed under Heat Stroke; 10 are open to participants now.

This study's planned enrollment of 1 is below the median of 34 across 13 interventional studies indexed under Heat Stroke.

Browse Heat Stroke studies →

Lead sponsor

Hospital General de Mexicali is the lead sponsor of 4 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Admitted to the General Hospital of Mexicali with the diagnosis of heat stroke.
  • Meeting the operational definition (exposure to heat, body temperature at admission greater than 40 degrees Celsius).
  • CPK level greater than 1000 U/L.
  • Having from the patient or the legally responsible adult.

Exclusion criteria

Exclusion Criteria:

  • Exclusion of the heat stroke diagnosis during their evaluation.
  • Lack of serum creatinine levels at the time of admission to the protocol.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1 participant (estimated)

Study arms

  • Experimental
    Intervention Group

    This group will receive 100 mEq of sodium bicarbonate diluted in one liter of saline solution, administered at a rate of 100 ml/h, with the goal of maintaining a urinary pH greater than 6.5.

    Drug: Sodium bicarbonate

  • Active comparator
    Control Group

    This group will be manage with the usual care that is given to patients with heat stroke in this hospital.

    Other: No intervention

Interventions

  • This group will receive 100 mEq of sodium bicarbonate diluted in one liter of saline solution, administered at a rate of 100 ml/h, with the goal of maintaining a urinary pH greater than 6.5.

  • OtherNo intervention

    The usual management for heat stroke will be given to this group

    Also known as: Control Group

06

What researchers measure

Primary outcomes

  1. The use of sodium bicarbonate reduces the need for renal replacement therapy

    Determine if the use of sodium bicarbonate as a prophylactic measure reduces the need for renal replacement therapy in patients with heat stroke-associated rhabdomyolysis.

    Time frame: From enrollment until discharge or death.

Secondary outcomes

  1. Creatinine levels

    Describe the creatinine levels of patients diagnosed with heat stroke at the General Hospital of Mexicali.

    Time frame: From enrollment until discharge or death.

  2. Mortality rate

    Determine the mortality rate of patients admitted with the diagnosis of heat stroke at the General Hospital of Mexicali.

    Time frame: From enrollment until discharge or death.

  3. Mortality rate of patients diagnosed with heat stroke who were administered bicarbonate compared to those who did not receive bicarbonate.

    Determine the mortality rate of patients diagnosed with heat stroke who were administered bicarbonate compared to those who did not receive bicarbonate.

    Time frame: From enrollment until discharge or death.

  4. Potassium levels in patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.

    Describe the potassium levels in patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.

    Time frame: From enrollment until discharge or death.

  5. Difference in the length of hospital stay for patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.

    Determine if there is a difference in the length of hospital stay for patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.

    Time frame: From enrollment until discharge or death.

  6. Difference in the requirements for vasopressors in patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.

    Establish if there is a difference in the requirements for vasopressors in patients

    Time frame: From enrollment until discharge or death.

  7. Use of mechanical ventilation in patients diagnosed with heat stroke

    Establish if there is a difference in the use of mechanical ventilation in patients diagnosed with heat stroke who received bicarbonate compared to those who did not receive bicarbonate.

    Time frame: From enrollment until discharge or death.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Bouchama A, Knochel JP. Heat stroke. N Engl J Med. 2002 Jun 20;346(25):1978-88. doi: 10.1056/NEJMra011089. No abstract available. PubMed 12075060 ↗

Individual participant data

Plan to share: No — There will be no disclousure of the patients information to thrid party members.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2024 (actual). Primary completion is estimated for Oct 2025, 17 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 6, 2024
First posted
Oct 2, 2024
StartActual
May 1, 2024
Primary completionEst.
Oct 1, 2025
CompletionEst.
Oct 1, 2025
Last update
Oct 2, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06622525
Lead sponsor
Hospital General de Mexicali
Collaborators
Universidad Autonoma de Baja California
Responsible party
Sponsor
First posted
Oct 2, 2024
Start date
May 1, 2024
Primary completion
Oct 1, 2025 (estimated)
Completion
Oct 1, 2025 (estimated)
Last update
Oct 2, 2024

Study contacts

Joaquin Cordova Erberk, MD
Contact
joaquincerberk@gmail.com
+52 653 132 0309
Hiram J Jaramillo Ramirez, MD
Contact
grupoinvestigacionmedica@gmail.com
+52 653 132 0309
Hiram J Jaramillo Ramirez, MD
principal investigator · Hospital General de Mexicali

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Sodium Bicarbonate

Start the discussion